Clinical Trials Browser

Phase 4 × Neoplasm, Residual × aldesleukin × Clear all

NCT01347996 2017-11-29

Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia

Phase 4 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Neoplasm, Residual